Drugs / Fenfuro
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03066089 | Dec 2015 → Oct 2017 | type 2 diabetes mellitus | Chemical Resources | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fenfuro | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03066089 ↗ |
| Route | Oral | “Fenfuro 500 mg capsule by mouth, BD (two times a day), till next follow-up” NCT03066089 ↗ |